Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $162.45 -0.16%
EPS Growth %: -4.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -4.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
